Chargement en cours...
Bisphosphonates and atypical subtrochanteric fractures of the femur
OBJECTIVES: Bisphosphonates are widely used as first-line treatment for primary and secondary prevention of fragility fractures. Whilst they have proved effective in this role, there is growing concern over their long-term use, with much evidence linking bisphosphonate-related suppression of bone re...
Enregistré dans:
| Publié dans: | Bone Joint Res |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5376663/ https://ncbi.nlm.nih.gov/pubmed/28288986 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1302/2046-3758.63.BJR-2016-0125.R1 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|